HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

W-L Listerine Anticaries Fluoride Rinse Formula Change Proposed To FDA

This article was originally published in The Tan Sheet

Executive Summary

Warner-Lambert has changed its proposed fluoride-containing oral anticaries/antiplaque/antigingivitis rinse to a .02% sodium fluoride formula to reflect results from recently conducted market research on taste, the company says in comments submitted to FDA May 15.

You may also be interested in...



Colgate 2in1 Toothpaste/Mouthwash Combo Opens New Oral Care Category

Colgate 2in1 Toothpaste and Mouthwash, which combines ingredients from both products in a light, foaming gel, will be launched in September, Colgate-Palmolive announced July 5. Ads from Young & Rubicam will break in November. Other promotional plans include sampling, Internet-based programs and direct mail.

W-L FreshBurst Listerine Expanded Anticaries Clinical Test Urged By FDA

Potential changes to the anticaries and antiplaque/antigingivitis monographs to allow a crossover product must be accompanied by stronger clinical studies than proposed by Warner-Lambert for FreshBurst Listerine With Fluoride, FDA advised the company at an OTC drug "feedback" meeting in Rockville, Md. June 6.

FDA May Amend Anticaries Monograph To Allow Combo Antiplaque Products

FDA may be amenable to an oral rinse product that crosses the anticaries and antiplaque/antigingivitis monographs if studies demonstrate safety and efficacy, agency officials told Warner-Lambert at an OTC "feedback" meeting in Rockville, Md. Oct. 8.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel